Pillar Biosciences Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 94

Employees
  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $20M

  • Investors
  • 5

Pillar Biosciences General Information

Description

Developer of targeted next-generation sequencing (NGS)-based software intended to enable access to accurate testing. The company's platform offers an economical workflow with high mapping and on-target metrics technology for cell-free DNA in order to develop medical research accessible through cost-effective sequencing combined with bioinformatics analyses, enabling the healthcare industry to simplify DNA analysis functions in an efficient manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 9 Strathmore Road
  • Natick, MA 01760
  • United States
+1 (800) 000-0000

Pillar Biosciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pillar Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 03-Jun-2021 $20M 000.00 00000 Completed Generating Revenue
5. Debt - PPP 02-May-2020 00000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Mar-2020 000.00 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Nov-2018 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A2) 11-May-2016 $18M $20.8M 000.00 Completed Product In Beta Test
1. Angel (individual) $2.8M $2.8M 0000 Completed Product In Beta Test
To view Pillar Biosciences’s complete valuation and funding history, request access »

Pillar Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 6,853,820 $0.000100 8% $2.63 $2.63 1x $2.63 13.92%
Series A1 5,466,965 $0.000100 8% $0.53 $0.53 1x $0.53 11.11%
To view Pillar Biosciences’s complete cap table history, request access »

Pillar Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of targeted next-generation sequencing (NGS)-based software intended to enable access to accurate testing. The
Decision/Risk Analysis
Natick, MA
94 As of 2022
000.00
0000 0000-00-00
00000000000 000.00

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
000000000 00000 (0000000000)
Hayward, CA
00 As of 0000
000
000000000 - 000

000000

is nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
00000 0000000000 0000000000 0000000
Saint Sulpice, Switzerland
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pillar Biosciences Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Paragon Genomics Venture Capital-Backed Hayward, CA 00 000 000000000 - 000
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
00000 000000000 Venture Capital-Backed San Diego, CA 00 00000 000000000000
00000000 000000000 Formerly VC-backed Seattle, WA 000 00000 00000000 00000
000000 00000000 Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 26 competitors. Get the full list »

Pillar Biosciences Patents

Pillar Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016289369-A1 Method for reducing primer-dimer amplification Active 07-Jul-2015 0000000000
AU-2016289369-B2 Method for reducing primer-dimer amplification Active 07-Jul-2015 0000000000
CA-2991401-A1 Method for reducing primer-dimer amplification Pending 07-Jul-2015 0000000000
EP-3134554-A1 Method for reducing primer-dimer amplification Active 07-Jul-2015 0000000000
EP-3134554-B1 Method for reducing primer-dimer amplification Active 07-Jul-2015 C12Q1/6848
To view Pillar Biosciences’s complete patent history, request access »

Pillar Biosciences Executive Team (11)

Name Title Board Seat Contact Info
Randy Pritchard Chief Executive Officer & Board Member
Vincent Ricci Chief Financial Officer
Zhaohui Wang Ph.D Chief Scientific Officer & Co-Founder
Daniel Harma Chief Commercial Officer
Martin Zillmann Ph.D Principal Process Development Scientist
You’re viewing 5 of 11 executive team members. Get the full list »

Pillar Biosciences Board Members (9)

Name Representing Role Since
Elaine Yang Self Board Member 000 0000
Eric Lai Ph.D Pillar Biosciences Board Member 000 0000
Gang Song Ph.D Pillar Biosciences Founder & Chairman of the Board 000 0000
Hong Fang Song Self Board Member 000 0000
Hui Yang Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Pillar Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pillar Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
HB Ventures (Hong Kong) Venture Capital Minority 000 0000 000000 0
China Biotech Services Holdings Corporation Minority 000 0000 000000 0
Oriental Fortune Capital Venture Capital Minority 000 0000 000000 0
ORI Capital Venture Capital Minority 000 0000 000000 0
ZhenFund Venture Capital Minority 000 0000 000000 0
To view Pillar Biosciences’s complete investors history, request access »